Appointments at PhRMA, BIO, Shire, Eli Lilly and DPT Laboratories – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Pharmaceutical companies of the united states Medicine Vice president

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PhRMA, BIO, Shire, Eli Lilly and DPT Laboratories.

ThePharmaceutical Research and Manufacturers of America ​(PhRMA​) has named Josephine Martin​ as executive vice president (EVP) of public affairs. Martin joins PhRMA from Ketchum where she held a similar position.

David Greenwood ​has been appointed interim-CEO and member of the board of directors at Geron ​following the departure of Thomas Okarma​. Also, Alexander Barkas​, chairman of the board, becomes lead independent director.

Shire​ has strengthened its R&D team with two appointments. Lawson Macartney​, who worked at GlaxoSmithKline for 20 years, joins as SVP of the emerging business unit, and Mario Saltarelli​, formerly of Abbott, is now SVP of clinical development and medical affairs.

Grant Gilker​ has been named general manager, operations for the DPT Laboratories​’ semi-solids and liquids manufacturing facility in San Antonio, Texas, US. Gilker has 21 years of pharma manufacturing experience working at companies including Pharmetics and Patheon.

Eli Lilly​ has promoted Sue Mahony​ to SVP and president of the oncology unit. Mahony, formerly SVP of human resources, succeeds John Johnson​ who resigned last month. Before joining Lilly Mahony worked at Amgen, Bristol-Myers Squibb, and Schering-Plough.

Peter Pellerito ​has been appointed interim-VP for state government relations and alliance development at the Biotechnology Industry Organization​ (BIO​). Pellerito has served as a consultant to BIO since 1995.

Optimer Pharmaceuticals ​has hired Glenn Tillotson​, formerly of ViroPharma,​as SVP of medical affairs. Also, Sherwood Gorbach​ is now chief scientific officer and SVP of R&D and Marc Lesnick​ has been promoted to the newly-created position of VP of regulatory affairs.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more